Pharmaceutical Sciences
Scope & Guideline
Bridging research and practice to transform healthcare.
Introduction
Aims and Scopes
- Drug Development and Formulation:
The journal emphasizes the process of drug discovery and formulation, focusing on novel drug delivery systems, formulation techniques, and the physicochemical properties that affect drug efficacy. - Nanotechnology and Drug Delivery Systems:
There is a significant focus on the integration of nanotechnology in pharmaceutical sciences, including the design and evaluation of nanoparticles, nanocarriers, and their applications in improving drug bioavailability and targeting. - Clinical Pharmacology and Therapeutics:
Research on the clinical efficacy and safety of drugs, including randomized controlled trials and pharmacoeconomic analyses, is a core area, providing evidence-based insights into therapeutic interventions. - Biopharmaceuticals and Biotechnology:
The journal explores biopharmaceutical advancements, including monoclonal antibodies, vaccines, and biologics, along with their formulation and delivery challenges. - Natural Products and Herbal Medicine:
There is a growing interest in the pharmacological evaluation of natural products, herbal formulations, and their potential therapeutic roles, which is reflected in numerous articles addressing their efficacy and mechanisms. - Toxicology and Safety Assessments:
The journal includes studies on the toxicity and safety of pharmaceutical compounds, including preclinical and clinical evaluations, which are crucial for regulatory approvals. - Pharmacogenomics and Personalized Medicine:
Research into how genetic variations affect individual responses to drugs, paving the way for personalized therapeutic strategies, is increasingly represented in the journal.
Trending and Emerging
- Nanomedicine and Targeted Therapies:
There is a marked increase in research focused on nanomedicine, including targeted drug delivery systems that enhance therapeutic efficacy while minimizing side effects, indicating a shift towards more precise treatment modalities. - Artificial Intelligence in Drug Discovery:
The application of artificial intelligence and machine learning in drug discovery processes is rapidly emerging, facilitating faster and more efficient identification of potential drug candidates and optimization of formulations. - Biologics and Biosimilars:
Research into biologics, including monoclonal antibodies and biosimilars, is on the rise, reflecting the growing importance of these therapies in treating chronic and complex diseases. - Personalized and Precision Medicine:
There is a growing emphasis on personalized medicine approaches that tailor treatments based on individual genetic profiles, leading to improved patient outcomes and reduced adverse effects. - Sustainable and Green Chemistry:
The incorporation of green chemistry principles in pharmaceutical development is becoming increasingly relevant, as researchers seek to minimize environmental impacts and enhance the sustainability of pharmaceutical processes. - Pharmacogenomics and Tailored Therapies:
Research exploring the intersection of pharmacogenomics and tailored therapeutic strategies is gaining momentum, highlighting the importance of genetic factors in drug metabolism and efficacy.
Declining or Waning
- Traditional Pharmaceutical Chemistry:
The emphasis on classical synthetic organic chemistry methods has waned, with a noticeable decrease in publications focused solely on traditional chemical synthesis without the integration of modern techniques such as computer-aided drug design or nanotechnology. - Invasive Clinical Trials:
There has been a shift away from invasive clinical trials in favor of non-invasive methods and observational studies, reflecting a broader trend towards patient safety and ethical considerations in clinical research. - Conventional Drug Formulations:
Research on conventional drug formulations, particularly those lacking innovative delivery methods, is declining as the field moves towards more sophisticated, targeted, and personalized drug delivery systems. - Single-Target Drug Approaches:
The focus on single-target drug discovery is decreasing, with a growing preference for polypharmacology and combination therapies that target multiple pathways for more effective treatment outcomes.
Similar Journals
Turkish Journal of Pharmaceutical Sciences
Empowering Researchers in Pharmaceutical SciencesThe Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.
Research in Pharmaceutical Sciences
Transforming Discoveries into Therapeutic SolutionsResearch in Pharmaceutical Sciences is a premier, peer-reviewed journal published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of pharmacology, toxicology, and pharmaceutics. With an impact factor that positions it in the second quartile of its category (Q2) and a respectable rank of 23 out of 80 in Scopus, this journal serves as an essential platform for researchers, professionals, and students alike, providing open access since 2015 to a wealth of pioneering studies and comprehensive reviews. Based in Mumbai, India, the journal encompasses a diverse range of topics within the pharmaceutical sciences, offering insights that address both theoretical and practical challenges in drug development and safety. As it converges from 2009 to 2024, Research in Pharmaceutical Sciences continues to be a vital source of knowledge, promoting innovation and fostering collaboration within the global scientific community.
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Fostering Excellence in Biomedical and Pharmaceutical DiscourseBIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.
JOURNAL OF PHARMACEUTICAL SCIENCES
Elevating research standards in the realm of pharmaceutics.The JOURNAL OF PHARMACEUTICAL SCIENCES, published by ELSEVIER SCIENCE INC, stands as a cornerstone in the field of pharmaceutical sciences, offering a platform for innovative research and advancements since its inception in 1961. With an impressive Scopus Rank of #36 out of 183 in the Pharmaceutical Science category, this journal is recognized for its commitment to disseminating high-quality, peer-reviewed studies that significantly contribute to the realms of pharmacology, toxicology, and pharmaceutics. Holding a 2023 Q2 category quartile, it attracts a diverse readership encompassing researchers, industry professionals, and students eager to advance their understanding and expertise. While the journal is not open access, it ensures valuable insights in every issue, making it an essential resource for those dedicated to the evolving landscape of pharmaceutical research. With an impact factor that reflects its relevance and influence, the JOURNAL OF PHARMACEUTICAL SCIENCES continues to shape the discourse in its domain, fostering innovation and collaboration among scholars worldwide.
Advances in Pharmacology and Pharmacy
Exploring Innovations in Pharmaceutical ScienceAdvances in Pharmacology and Pharmacy is a pioneering journal devoted to the dissemination of cutting-edge research in the fields of pharmacology and pharmaceutical sciences. Published by Horizon Research Publishing, this peer-reviewed journal boasts a commitment to advancing knowledge and innovation, making it an essential resource for researchers, industry professionals, and students alike. With an ISSN of 2332-0036 and an E-ISSN of 2332-0044, it provides a platform for high-quality research articles that explore new therapeutic approaches, drug development strategies, and the regulatory aspects of pharmaceutical science. Although currently lacking a formal impact factor, the journal's emphasis on open access ensures that articles are widely available, promoting the sharing of valuable insights and collaborative efforts in the scientific community. Located at 506 N Garfield Ave, Ste 210, Alhambra, CA 91801, the journal welcomes contributions from diverse areas within pharmacology and pharmacy, reinforcing its significance as a vital resource in the ever-evolving landscape of pharmaceutical research.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
Innovating the future of pharmacology and toxicology.YAKUGAKU ZASSHI - JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, published by the Pharmaceutical Society of Japan, is a key academic journal dedicated to advancing the field of pharmaceutical sciences. Established in 1961 and set to contribute until 2024, this journal publishes original research articles, reviews, and clinical studies that encompass a wide spectrum of topics within pharmacology, toxicology, and pharmaceutics. Although the journal operates under a traditional subscription model, it maintains a recognized reputation with an impact factor that is steadily aligned within its category quartiles—ranking Q3 in Pharmaceutical Science and Q4 in Pharmacology as of 2023. With Scopus rankings reflecting its competitive standing, YAKUGAKU ZASSHI serves as a vital resource for researchers, professionals, and students looking to engage with innovative findings and broaden their understanding of pharmaceutical methodologies and research practices. With a current focus on bridging scientific research with real-world applications, it seeks to foster collaboration and knowledge sharing within the pharmaceutical community.
PHARMACIA
Exploring the frontiers of drug development and therapeutic science.PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.
BIOCHEMICAL PHARMACOLOGY
Delivering critical insights for the future of pharmacology.BIOCHEMICAL PHARMACOLOGY, published by PERGAMON-ELSEVIER SCIENCE LTD, stands as a leading international journal devoted to the advancing field of biochemical pharmacology. Since its inception in 1958, the journal has continuously offered a platform for innovative research, delivering critical insights into the interaction between biochemical processes and pharmaceutical applications, and now converges towards its 2024 edition. With an impressive Q1 ranking in both Biochemistry and Pharmacology categories, it ranks 32nd out of 313 in Pharmacology and Toxicology, and 58th out of 438 in Biochemistry according to Scopus, showcasing its significant impact within the scientific community. Researchers and professionals rely on this journal to keep abreast of essential developments, given its robust peer-review process and a comprehensive selection of articles that span experimental studies, clinical trials, and theoretical analyses. Although not an Open Access journal, it remains pivotal for those seeking to advance their knowledge in the dynamic fields of biochemistry and pharmacology. With its high impact factor and emphasis on quality research, BIOCHEMICAL PHARMACOLOGY continues to be an invaluable resource for students, researchers, and industry professionals striving to make breakthroughs in drug development and therapeutic strategies.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Exploring the Frontiers of Drug DevelopmentCURRENT PHARMACEUTICAL BIOTECHNOLOGY is a prestigious academic journal dedicated to advancing the field of pharmaceutical biotechnology by publishing high-quality research articles, reviews, and innovatory methodologies. Published by Bentham Science Publishers Ltd, this journal has established a strong reputation in its field, reflected in its 2023 Scopus rankings: it holds an impressive Q2 classification in Pharmaceutical Science and Q3 in Biotechnology, indicating its significant impact within these disciplines. With an ISSN of 1389-2010 and an E-ISSN of 1873-4316, CURRENT PHARMACEUTICAL BIOTECHNOLOGY provides a reliable platform for disseminating valuable research findings and fostering collaboration among researchers, professionals, and students alike. The journal covers a wide array of topics, from drug development and delivery systems to innovative biotechnological techniques, thus serving as an essential resource for anyone interested in the cross-section of pharmaceutical science and biotechnology. Researchers can access a diverse range of articles that explore both theoretical frameworks and practical applications, reflecting the ongoing evolution and challenges in this dynamic field.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
Fostering breakthroughs in drug development and application.Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.